Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lexaria Bioscience Corp. Director's Dealing 2009

Jul 10, 2009

34983_dirs_2009-07-10_2239b699-adc7-49fc-8ea5-4f6aa621faeb.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2009-07-08

Reporting Person: BUNKA CHRISTOPHER (Director, Chairman/President/CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-07-10 Common Shares P 1600000 $0.05 Acquired 1988213 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-07-10 Warrants $0.2 P 1600000 Acquired 2011-07-10 Common Shares (1600000) Indirect
2009-07-08 Stock Options $0.2 P 18750 Acquired 2011-07-20 Common Shares (18750) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares 215.75 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants $2.4 2009-11-09 Common Shares (291700) 291700 Indirect
Stock Options $0.2 2011-04-26 Common Shares (100000) 100000 Direct
Stock Options $0.2 2011-07-20 Common Shares (100000) 100000 Direct

Footnotes

F1: Chris Bunka is the sole owner of CAB Financial Services Ltd.

F2: On July 8, 2009 the exercise price was reduced from $0.80.

F3: On July 8, 2009, the exercise price was chaged from $0.12.